Dana Farber Cancer Institute at St. Elizabeth's — Brighton, Massachusetts

Dana Farber Cancer Institute at St. Elizabeth's is a clinical research site located in Brighton, Massachusetts, United States 02135.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute at St. Elizabeth's has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.

Sponsors: Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute at St. Elizabeth's?

Dana Farber Cancer Institute at St. Elizabeth's has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute at St. Elizabeth's conducted?

Dana Farber Cancer Institute at St. Elizabeth's has 1 clinical trials on record, with 1 currently active. Their work covers Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.

Is Dana Farber Cancer Institute at St. Elizabeth's accredited by Crixeo Health?

Dana Farber Cancer Institute at St. Elizabeth's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute at St. Elizabeth's?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.